Filing Details
- Accession Number:
- 0001179110-16-028198
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-03 16:07:39
- Reporting Period:
- 2016-08-01
- Filing Date:
- 2016-08-03
- Accepted Time:
- 2016-08-03 16:07:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1021038 | A Henri Termeer | C/O Abiomed, Inc. 22 Cherry Hill Drive Danvers MA 01923 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.01 Par Value | Acquisiton | 2016-08-01 | 8,000 | $13.21 | 325,778 | No | 4 | M | Direct | |
Common Stock, $0.01 Par Value | Disposition | 2016-08-01 | 3,744 | $118.70 | 322,034 | No | 4 | S | Direct | |
Common Stock, $0.01 Par Value | Acquisiton | 2016-08-01 | 8,000 | $12.69 | 330,034 | No | 4 | M | Direct | |
Common Stock, $0.01 Par Value | Disposition | 2016-08-01 | 3,991 | $118.70 | 326,043 | No | 4 | S | Direct | |
Common Stock, $0.01 Par Value | Acquisiton | 2016-08-01 | 12,000 | $18.63 | 338,043 | No | 4 | M | Direct | |
Common Stock, $0.01 Par Value | Disposition | 2016-08-01 | 6,409 | $118.70 | 331,634 | No | 4 | S | Direct | |
Common Stock, $0.01 Par Value | Acquisiton | 2016-08-01 | 12,000 | $7.67 | 343,634 | No | 4 | M | Direct | |
Common Stock, $0.01 Par Value | Disposition | 2016-08-01 | 5,796 | $118.70 | 337,838 | No | 4 | S | Direct | |
Common Stock, $0.01 Par Value | Acquisiton | 2016-08-01 | 12,000 | $9.99 | 349,838 | No | 4 | M | Direct | |
Common Stock, $0.01 Par Value | Disposition | 2016-08-01 | 5,926 | $118.70 | 343,912 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2016-08-01 | 8,000 | $0.00 | 8,000 | $13.21 |
Common Stock | Stock option (right to buy) | Disposition | 2016-08-01 | 8,000 | $0.00 | 8,000 | $12.69 |
Common Stock | Stock Option (right to buy) | Disposition | 2016-08-01 | 12,000 | $0.00 | 12,000 | $18.63 |
Common Stock | Stock Option (right to buy) | Disposition | 2016-08-01 | 12,000 | $0.00 | 12,000 | $7.67 |
Common Stock | Stock Options (right to buy) | Disposition | 2016-08-01 | 12,000 | $0.00 | 12,000 | $9.99 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2007-08-08 | 2016-08-09 | No | 4 | M | Direct |
0 | 2008-08-13 | 2017-08-08 | No | 4 | M | Direct |
0 | 2009-08-12 | 2018-08-13 | No | 4 | M | Direct |
0 | 2010-08-11 | 2019-08-12 | No | 4 | M | Direct |
0 | 2011-08-10 | 2020-08-11 | No | 4 | M | Direct |
Footnotes
- This option becomes exercisable in full on the date set forth in Table II, Column 6.
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2000 Stock Incentive Plan.
- Grant to reporting person of option to buy shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- Transaction represents sale of shares with proceeds delivered to the issuer for payment of exercise price of options under the issuer's employee stock option plan and the related tax withholding.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $118.1200 and $119.0300. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.